Adalimumab/etanerceptOptic neuritis: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1439卷 / 1期

关键词：

D O I：

10.1007/s40278-013-1339-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[21] Adalimumab/etanerceptInjection site reactions: 4 case reports
Reactions Weekly, 2008, 1184 (1) : 6 - 6
[22] Adalimumab/cyclophosphamide/methylprednisoloneBrain tuberculoma: 4 case reports
Reactions Weekly, 2016, 1601 (1) : 18 - 18
[23] Adalimumab/etanercept/infliximabLung disorders: 4 case reports
Reactions Weekly, 2008, 1210 (1) : 6 - 6
[24] Adalimumab/infliximab/ustekinumabHerpes zoster: 4 case reports
Reactions Weekly, 2015, 1547 (1) : 16 - 16
[25] Adalimumab/etanercept/infliximabSkin reactions: 4 case reports
Reactions Weekly, 2012, 1417 (1) : 6 - 6
[26] Immunosuppressants/adalimumab/infliximabVisual loss: 4 case reports
Reactions Weekly, 2016, 1591 (1) : 103 - 103
[27] Adalimumab/etanercept/infliximabSkin reactions: 4 case reports
Reactions Weekly, 2009, 1260 (1) : 6 - 6
[28] Adalimumab/azathioprine/infliximabReactivation of TB: 4 case reports
Reactions Weekly, 2019, 1762 (1) : 17 - 17
[29] Adalimumab/infliximab/methotrexateVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1753 (1) : 14 - 14
[30] Adalimumab/infliximabCNS demyelinating disease, peripheral neuropathy and recurrent optic neuritis: 3 case reports
Reactions Weekly, 2015, 1551 (1) : 14 - 14

← 1 2 3 4 5 →